Company Directory / Pharmaceuticals

PrivateFor profitPharmaceuticalsHemel Hempstead, Hertfordshire, United Kingdom
EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research,… Read all
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.
Size
51-100 people: larger than 75% of companies with a size listed. 98 people list it on LinkedIn.
Age
20 years old.
Reach
Website ranked #11,672,315 in the world for traffic, about 154 visits a month. 13,539 followers on LinkedIn.
BiotechnologyHealth CareMedicalOncologyPharmaceuticalRare DiseasesOncology ProductsOncology Supportive Care
Funding, as listed
$54M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about EUSA Pharma, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
EUSA Pharma may be growing as indicated by a significant financial transaction where Recordati agreed to pay 750 million euros for the company, suggesting a substantial valuation and confidence in its future prospects. Additionally, EUSA Pharma is mentioned in the context of a growing oral mucositis treatment drug market, which is expanding rapidly and includes the company as a major player. The company is also listed among key companies in a market projected to grow during the study period of 2019-2032, further indicating its involvement in expanding markets.
Summaries written by the source dataset, not by us, and not checked.
Pharmaceuticals in United Kingdom.
Ferring Controlled TherapeuticsEast Kilbride · 5001-10000 people · 1k followers
Oxford BioMedicaOxford · 501-1000 people · 47k followers
Redx PharmaAlderley Park · 51-100 people · 12k followers
Archimedes PharmaReading · 51-100 people · 4k followersCCellZome51-100 people · 2k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.